The BIT drug trial mentions no effect on CD4+ T cells which are the main barrier to a cure.
https://www.genengnews.com/topics/g...tent-hiv-1-offering-hope-of-functional-cures/
CD4+ T cells have been the most studied of the cellular reservoirs in which HIV-1 can persist. A small fraction of resting CD4+ T cells will harbor HIV-1, even during ART, and are considered to be “the major obstacle to HIV-1 eradication,” the authors point out. “Latent HIV-1 infection in resting CD4+ T cells is the primary cause of the barrier to a functional cure.”
$10 Billion Deal, page-130
-
- There are more pages in this discussion • 13,222 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 968248 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 900263 | 3 |
View Market Depth
| Last trade - 16.12pm 08/10/2024 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable